Podobnik Petra, Meštrović Tomislav, Đorđević Aida, Kurdija Kristian, Jelčić Dženis, Ogrin Nina, Bertović-Žunec Ivan, Gebauer-Vuković Beata, Hočevar Grega, Lončar Igor, Srebreniković Zlata, Trobina Petra, Bitenc Marko, Dumić-Čule Ivo
Podobnik Special Hospital, Ul. Sveti Duh 112, 10000 Zagreb, Croatia.
DA VINCI Polyclinic, Petrovaradinska ulica 110, 10000 Zagreb, Croatia.
Genes (Basel). 2024 Dec 11;15(12):1590. doi: 10.3390/genes15121590.
Chromosomal numerical and structural alterations are significant causes of various developmental disorders in foetuses. Non-invasive prenatal testing (NIPT) has emerged as an effective screening tool for detecting common aneuploidies, aiding in the identification of individuals who may require further diagnostic work-up.
This retrospective, monocentric observational study evaluates the usage patterns, test choices, turnaround times (TAT), and outcomes of NIPT between 2013 and 2023 on a sample of 2431 pregnant women at a special hospital offering outpatient services and comprehensive gynaecological/obstetric inpatient care. We analysed the trends in NIPT usage, high-risk results, prior screening procedures, as well as factors such as age, gestational age and in vitro fertilisation (IVF) status. NIPT was performed using cell-free foetal DNA (cffDNA) extracted from maternal plasma, followed by library construction, sequencing and result analysis. The sequencing results were aligned with reference genomes, and z-scores were calculated to assess the likelihood of aneuploidy. Statistical significance was set at < 0.05.
The average age of women undergoing NIPT decreased from 36.1 years in 2013 to 33.01 years in 2023 ( = 0.0287), and mean TAT dropped from 12.44 days in 2013 to 7.08 days in 2023 ( = 0.0121), with the most substantial reduction occurring between 2013 and 2019. The study identified a stable rate of women who underwent IVF seeking prenatal testing, with no statistically significant difference between the first half and the second half of the analysed period ( = 0.2659). Among high-risk results, there were 39 chromosomal abnormalities detected, most of them belonging to trisomy 21 (59%).
Our findings demonstrate the increasing efficiency and accessibility of NIPT in prenatal care in Croatia, while the significant reduction in TAT and the decreasing age of women undergoing NIPT reflect enhanced operational practices and broader acceptance. Introducing NIPT into the public healthcare system in the Republic of Croatia could improve equitable access to advanced prenatal care and enhance pregnancy outcomes. Future advancements in technology and genetic counselling will further enhance its role, requiring careful attention to ethical and regulatory considerations.
染色体数目和结构改变是胎儿各种发育障碍的重要原因。无创产前检测(NIPT)已成为检测常见非整倍体的有效筛查工具,有助于识别可能需要进一步诊断检查的个体。
这项回顾性、单中心观察性研究评估了2013年至2023年期间,在一家提供门诊服务以及全面妇科/产科住院护理的专科医院中,2431名孕妇样本的NIPT使用模式、检测选择、周转时间(TAT)和结果。我们分析了NIPT使用趋势、高危结果、先前的筛查程序,以及年龄、孕周和体外受精(IVF)状态等因素。使用从母血血浆中提取的游离胎儿DNA(cffDNA)进行NIPT,随后进行文库构建、测序和结果分析。将测序结果与参考基因组比对,并计算z值以评估非整倍体的可能性。设定统计学显著性为<0.05。
接受NIPT的女性平均年龄从2013年的36.1岁降至2023年的33.01岁( = 0.0287),平均TAT从2013年的12.44天降至2023年的7.08天( = 0.0121),最大降幅发生在2013年至2019年之间。该研究发现寻求产前检测的IVF女性比例稳定,分析期的上半年和下半年之间无统计学显著差异( = 0.2659)。在高危结果中,检测到39例染色体异常,其中大多数属于21三体(59%)。
我们的研究结果表明,在克罗地亚的产前护理中,NIPT的效率和可及性不断提高,而TAT的显著缩短以及接受NIPT的女性年龄的降低反映了操作实践的改进和更广泛的接受度。将NIPT引入克罗地亚共和国的公共医疗系统可以改善公平获得先进产前护理的机会并提高妊娠结局。技术和遗传咨询方面的未来进展将进一步增强其作用,需要仔细关注伦理和监管考量。